Bortezomib augments lymphocyte stimulatory cytokine signaling in the tumor microenvironment to sustain CD8+T cell antitumor function.
about
Bortezomib augments lymphocyte stimulatory cytokine signaling in the tumor microenvironment to sustain CD8+T cell antitumor function.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bortezomib augments lymphocyte ...... CD8+T cell antitumor function.
@en
Bortezomib augments lymphocyte ...... CD8+T cell antitumor function.
@nl
type
label
Bortezomib augments lymphocyte ...... CD8+T cell antitumor function.
@en
Bortezomib augments lymphocyte ...... CD8+T cell antitumor function.
@nl
prefLabel
Bortezomib augments lymphocyte ...... CD8+T cell antitumor function.
@en
Bortezomib augments lymphocyte ...... CD8+T cell antitumor function.
@nl
P2093
P2860
P356
P1433
P1476
Bortezomib augments lymphocyte ...... CD8+T cell antitumor function
@en
P2093
Anil Shanker
Ann Richmond
Duafalia F Dudimah
Menaka C Thounaojam
Roman V Uzhachenko
Samuel T Pellom
P2860
P304
P356
10.18632/ONCOTARGET.14365
P407
P50
P577
2017-01-01T00:00:00Z